Medicus Pharma Ltd. Common Stock
Medicus Pharma Ltd., a biotech/life sciences company, focuses on developing clinical development programs of therapeutic assets in the United States. It is developing SKNJCT-003, which is in Phase 2 study for the treatment of basal cell carcinoma of the skin. Medicus Pharma Ltd. has a strategic collaboration with the Gorlin Syndrome Alliance to access to SKINJECT in Patients with Gorlin Syndrome.… Read more
Medicus Pharma Ltd. Common Stock (MDCX) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 8.396x
Based on the latest financial reports, Medicus Pharma Ltd. Common Stock (MDCX) has a cash flow conversion efficiency ratio of 8.396x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-6.76 Million) by net assets ($-804.89K). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Medicus Pharma Ltd. Common Stock - Cash Flow Conversion Efficiency Trend (2010–2024)
This chart illustrates how Medicus Pharma Ltd. Common Stock's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Medicus Pharma Ltd. Common Stock Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Medicus Pharma Ltd. Common Stock ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Cadrenal Therapeutics, Inc. Common Stock
NASDAQ:CVKD
|
-0.862x |
|
Electromagnetica SA
RO:ELMA
|
0.031x |
|
Seojin Automotive Co.Ltd
KQ:122690
|
-0.029x |
|
Jayant Agro Organics Limited
NSE:JAYAGROGN
|
-0.075x |
|
Initiator Pharma A/S
ST:INIT
|
-0.144x |
|
Akobo Minerals AB (publ)
OL:AKOBO
|
0.133x |
|
The INX Digital Company Inc.
OTCQB:INXDF
|
-0.333x |
|
Galena Mining Ltd
AU:G1A
|
-0.086x |
Annual Cash Flow Conversion Efficiency for Medicus Pharma Ltd. Common Stock (2010–2024)
The table below shows the annual cash flow conversion efficiency of Medicus Pharma Ltd. Common Stock from 2010 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $3.13 Million | $-10.25 Million | -3.269x | +12.63% |
| 2023-12-31 | $1.11 Million | $-4.16 Million | -3.741x | -4417.13% |
| 2022-12-31 | $-12.20 Million | $-1.06 Million | 0.087x | -37.13% |
| 2021-12-31 | $-10.51 Million | $-1.45 Million | 0.138x | -86.91% |
| 2017-12-31 | $-62.65K | $-65.99K | 1.053x | +75.08% |
| 2010-12-31 | $-2.00 Million | $-1.20 Million | 0.602x | -- |